Skip to main content
. 2020 Jan 29;13:903–914. doi: 10.2147/OTT.S230847

Figure 1.

Figure 1

Correlation between ST6GAL2 expression and survival time of patients with breast cancer. (A, B) The expression level of ST6GAL2 detected by real-time PCR in breast cancer (n=40) and adjacent normal tissues (n=40) from patients at The First Affiliated Hospital of Zhejiang University. (C) The expression level of ST6GAL2 in breast cancer (n=1040) and adjacent normal tissues (n=112) from the TCGA database. Results are reported as mean ± SD and analyzed with Student’s t-test. (D) IHC staining of ST6GAL2 in breast cancer tissues from patients at The First Affiliated Hospital of Zhejiang University. Scale bars: 50 μm. (E, F) The survival time of breast cancer specimens from patients at The First Affiliated Hospital of Zhejiang University and TCGA database was estimated by the Kaplan–Meier method using the Log-rank test. *P<0.05, ***P<0.001 compared with normal.